Myotonic Dystrophy Type 2 Overview
Learn About Myotonic Dystrophy Type 2
- Myotonic dystrophy type 2
- DM2
- Dystrophia myotonica type 2
- Myotonic myopathy, proximal
- PROMM
- Proximal myotonic myopathy
- Ricker syndrome
Ucsf Medical Group Business Services
Jeffrey Ralph is a Neurologist and a Pediatrics provider in San Francisco, California. Dr. Ralph and is rated as an Advanced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. His top areas of expertise are Peripheral Neuropathy, Guillain-Barre Syndrome, Chronic Polyradiculoneuritis, and Miller-Fisher Syndrome.
Kun Huang is an Internal Medicine provider in Albany, California. Dr. Huang has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. Her top areas of expertise are Myositis, Dermatomyositis, Polymyositis, Vascular Ehlers-Danlos Syndrome (VEDS), and Lung Transplant.
Robert Miller is a Neurologist in San Francisco, California. Dr. Miller and is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. His top areas of expertise are Myasthenia Gravis, Emery-Dreifuss Muscular Dystrophy, X-Linked Dominant Scapuloperoneal Myopathy, and Walker-Warburg Syndrome.
Summary: Nearly two-third of patients with myotonic dystrophy type 2 (DM2) report that impaired cognition is among the most disabling symptoms and deeply affects their quality of life. Yet, relatively little is known about how DM2 affects brain structure and cognitive function as brain imaging studies in DM2 are extremely limited. This is a prospective, cross-sectional study of brain structure and function...
Summary: Myotonic dystrophy type 1 (DM1) is a neuromuscular disease characterized by multisystem manifestations. DM1 can affect the urinary system through the impact of the pelvic floor muscles (PFM). Urinary incontinence can occur in this situation and is often offset with compensatory measures without restoring the PFM function (e.g. sanitary pads). PFM training have already been shown to be effective in...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center